SCHEMBL5994239

SCHEMBL5994239

CCCCCCCCC(CC)COCCCO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.59
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
MMP14 P50281 1/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 3/20 0.48
HTT P42858 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
THRB P10828 1/20 0.46
MAPT P10636 1/20 0.46
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
ALDH1A1 P00352 3/20 0.44
TSHR P16473 3/20 0.41
HSD17B10 Q99714 1/20 0.41
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31601992 1.00 CYP3A4 (0.59) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31602038 1.00 CYP3A4 (0.59) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31602117 0.98 CYP3A4 (0.61) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31602164 0.97 CYP3A4 (0.56) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31602138 0.97 CYP3A4 (0.56) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31601969 0.95 CYP3A4 (0.57) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31602092 0.95 CYP3A4 (0.57) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31601983 0.95 CYP3A4 (0.57) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31602015 0.93 CYP3A4 (0.56) CYP3A4MMP9MMP8MMP14USP2
SCHEMBL31602022 0.93 CYP3A4 (0.56) CYP3A4MMP9MMP8MMP14USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7148375-B2 Branched primary alcohol compositions and derivatives thereof SHELL OIL COMPANY (US) 2006-12-12 US disclosed
US-7071364-B2 Branched primary alcohol compositions and derivatives thereof SHELL OIL COMPANY (US) 2006-07-04 US disclosed
US-6909020-B2 Branched primary alcohol compositions and derivatives thereof SHELL OIL COMPANY (US) 2005-06-21 US disclosed
US-6891056-B2 Branched primary alcohol compositions and derivatives thereof SHELL OIL COMPANY (US) 2005-05-10 US disclosed
US-20040198628-A1 Branched primary alcohol compositions and derivatives thereof EDWARDS CHARLES LEE (US) 2004-10-07 US disclosed
US-20040077894-A1 Branched primary alcohol compositions and derivatives thereof EDWARDS CHARLES LEE (US) 2004-04-22 US disclosed
US-20040073055-A1 Branched primary alcohol compositions and derivatives thereof EDWARDS CHARLES LEE (US) 2004-04-15 US disclosed
US-20040068133-A1 Branched primary alcohol compositions and derivatives thereof EDWARDS CHARLES LEE (US) 2004-04-08 US disclosed
US-20040067867-A1 Branched primary alcohol compositions and derivatives thereof EDWARDS CHARLES LEE (US) 2004-04-08 US disclosed
US-6706931-B2 COLD WATER SOLUBLE DETERGENTS EXHIBITING HIGH CALCIUM TOLERANCE PRODUCED FROM BIODEGRADABEL BRANCHED ETHER ALCOHOLS SHELL OIL COMPANY 2004-03-16 US disclosed
EP-1343861-A2 BRANCHED PRIMARY ALCOHOL COMPOSITIONS AND DERIVATIVES THEREOF SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 2003-09-17 EP disclosed
US-20020151738-A1 Branched primary alcohol compositions and derivatives thereof SHELL OIL COMPANY 2002-10-17 US disclosed
WO-2002050006-A2 BRANCHED PRIMARY ALCOHOL COMPOSITIONS AND DERIVATIVES THEREOF SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068133-A1 Branched primary alcohol compositions and derivatives thereof ADH1A, ADH1C, ADH5 CYP3A4 361/4885MMP9 4156/4885MMP8 4462/4885
US-20020151738-A1 Branched primary alcohol compositions and derivatives thereof ADH1A, ADH1C, ADH5 CYP3A4 361/4885MMP9 4156/4885MMP8 4462/4885
US-20040077894-A1 Branched primary alcohol compositions and derivatives thereof ADH1A, ADH1C, ADH5 CYP3A4 361/4885MMP9 4156/4885MMP8 4462/4885
US-20040073055-A1 Branched primary alcohol compositions and derivatives thereof ADH1A, ADH1C, ADH5 CYP3A4 361/4885MMP9 4156/4885MMP8 4462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.